Table 1.
Patient Demographics
| No. pts. | 62 |
|---|---|
| Mean age (range) | 65.1 (51–76) |
| Mean PSA (ng/ml, range) | 13.4 (3.69–41.6) |
| No. PSA (ng/ml) (%) | |
| <10.0 | 21 (33.9) |
| 10.0–20.0 | 29 (46.8) |
| >20.0 | 12 (19.4) |
| No. Gleason score (%) | |
| 2–6 | 17 (27.4) |
| 7 | 30 (48.4) |
| 8–10 | 15 (24.2) |
| No. highest Gleason pattern (%) | |
| 1 | 0 (0) |
| 2 | 7 (11.3) |
| 3 | 33 (53.2) |
| 4 | 15 (24.2) |
| 5 | 7 (11.3) |
| No. pathological stage (%) | |
| pT2a | 6 (9.7) |
| pT2b | 32 (51.6) |
| pT3a | 19 (30.6) |
| pT3b | 5 (8.1) |
| No. pos. capsular invasion (%) | 21 (33.9) |
| No. pos. surgical margin (%) | 31 (50.0) |
No. pts, number of patients, PSA, prostate specific antigen, pos., positive.